Wolverine Asset Management
NAUT icon

Wolverine Asset Management’s Nautilus Biotechnolgy NAUT Stock Holding History

Wolverine Asset Management’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-8,850
Closed -$95K – 1805
2020
Q3 		$95K Buy
+8,850
New +$94.4K ﹤0.01% 1147

Other funds holding NAUT

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlueCrest Capital Management
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
GL
Governors Lane New York $1.2B AUM 26.21% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Wolverine Asset Management's NAUT Position: Q4 2020 in Review

Wolverine Asset Management sold out of Nautilus Biotechnolgy (NAUT) in Q4 2020, closing a stake of 8,850 shares — an estimated $95K sold.

Wolverine Asset Management first reported a position in NAUT in Q3 2020 and held it in 1 quarter. The position peaked at $95K in Q3 2020. 43 funds tracked by Wall St. Rank hold NAUT as of Q4 2020.

  • Wolverine Asset Management reported no remaining Nautilus Biotechnolgy position as of Q4 2020 after selling out during the quarter.
  • Wolverine Asset Management sold 8,850 Nautilus Biotechnolgy shares in Q4 2020, an estimated $95K.
  • Wolverine Asset Management first reported a position in Nautilus Biotechnolgy in Q3 2020 and held it in 1 quarter.
  • Wolverine Asset Management's Nautilus Biotechnolgy position peaked at $95K in Q3 2020.
  • 43 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2020.

Based on Wolverine Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.